Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I suppose we're in the "wait and see" period where people try to scare each other into selling. LOL.
cb - you didn't actually say, in that post, that you planned to hold. Responding to Gandolf's message in which he was talking about selling, you said:
"Jack, thanks for your honest post.
Good luck to you.
Chris"
Sorry for misunderstanding, I mistakenly got the impression that you also were considering selling.
Actually, I've been following the company for years. I only became a stockholder this year. I plan to hold all of my shares, no matter what. It's a calculated risk, a certain way to play the game. I also plan to increase my holdings, as long as prospects for the company's future continue to improve, or at least don't degrade substantially.
So, Beckman Coulter and DNA Direct, no increase in revenue, by your reckoning? And no ability to further cut costs if/when needed, on the part of DNAPrint Genomics? If you think that, then I distinctly disagree, on both counts.
Down to .0048 (with highly suspicious tiny transactions pushing it down that far, in the last several days, as has been noted,) from .0065, "that's nothing," as my investment banker said; he bought in at around .007, and isn't worried at all by this. Watching PPS obsessively with an extreme value penny stock like this is just crazy. Anyone with a propensity to do that, has no business investing in extreme value (extremely high beta, extremely low price, extremely undervalued/underpriced,) penny stocks. There are reasons the stock is the price it is at, right now. None of which have to do with any recent negative changes in the stock's long term prospects. Investment like this requires discipline and a certain degree of perspective.
Why sell now? Oh well, I guess I'll just be able to buy DNAG cheaper, than if you guys didn't sell. Thanks for that.
Michiko, that's ok. Personally, I'm more convinced than ever. I'll be buying more DNAG stock as my portfolio grows (topping off to maintain a full position.) I'm tempted to go above a full position, but I try to stay diversified for good reasons, including not having my investment banker calling me crazy, LOL. He's got an in-your-face "type A" personality, and talks about as fast as Cramer does, let's put it that way. He told me he bought DNAG stock, along with me (soon after I made my first DNAG purchase. I've made several.) As a Wells Fargo investment banking VP, with more than 20 years experience, he looked into DNAG and decided to buy. Nothing but good news has happened since then, aside from the tight credit market which is now showing every sign of loosening up, finally. He's more encouraged with DNAG than ever, as am I. DNA Direct, Beckman Coulter, those kinds of things don't happen when a company has nothing.
Excuse me, but all the experts I've seen and read in interviews lately, have said that money is extremely tight recently. Even the "bread and butter" commercial paper has all but dried up. Bond rates lower than the Fed overnight rate, who would want to lend at a loss? With enough Fed reduction of the rate, then the money will flow again. That, and wrapping up all this subprime danger (including stopping the ARM interest rate increases, at least temporarily,) that's what all the talk is about, all over the financial media/press now. There's absolutely no reason to give up now. Talk about a light at the end of the tunnel; take off the sunglasses, and you may see what I'm talking about.
Michiko, "finally dead"? What do you mean? Most of us (myself included) are not selling, we think the company has a very good chance of not only surviving, but prospering in a huge way. Your question, "How long til we're finally dead?," sounds like a very bearish question, and as far as I can tell, you aren't bearish on DNAG?
I wonder if anyone has reported these obviously manipulative trades to the SEC.
Absolutely.
Funny you should ask. A "new low" was initiated by a very peculiar transaction, at the beginning of trading yesterday (Thursday, November 29.) A miniscule trade of 100 shares, for an unreasonably cheap $0.0047, was executed. Looks like manipulation, to me -- an attempt to push DNAG below .5 cents per share.
You can fool most of the people most of the time, but you can't fool me.
The latest news surrounding what Bernanke said earlier this evening:
http://news.google.com/news?hl=en&um=1&ie=UTF-8&tab=wn&q=bernanke
Easier funding seems to be not that far off, now.
Good point; people are holding their DNAG shares very tightly (wisely so, in my opinion!)
As the Fed has been making more noise in the direction of further rate cuts (Bernanke spoke this evening about it,) and many people are starting to call a bottom in the troubled financials, it may not be long until financing becomes more available, on more favorable terms, again. If DNAPrint hasn't secured something already, that could really help them. In the meantime, they have income streams to pull them through, with possibly dramatic increases in some of those streams, particularly with the newer deals (the DNA Direct arrangement, and Beckman Coulter sales and marketing agreement, come to mind, but there are also others.)
I think it is a calm, before a storm, but exactly which storm and when, we'll have to wait and see. Aside from the usual atrition due to impatience and bashing, the last two days have seen a lot of selloff in long-term positions (like DNAG) to reinvest in what people view as lucrative, short-to-medium term positions, with what they may perceive as a greater assurance of return. I sold a few stocks today, to buy into some more favorable ones (financial bottom fishing, like CFC,) but no way did I even consider selling any of my DNAG shares. I know what potential is in those.
This post in the Yahoo DNAG forum is interesting, I think:
http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_D/threadview?m=tm&bn=41619&tid=2322&mid=2352&tof=1&rt=2&frt=2&off=1
"dgplexus, I would agree with you. I emailed DNAG IR on the potential revenue from the recent agreements with DNA Direct, Bioserve, and Beckman. If you look at the presentation from September, it says it takes 90 days to get listed on the Euronext. Lets hope some info comes out soon."
Good point. That's a lot of hits for a "dead horse." DNAG is the best value I hold in my portfolio, in my opinion.
Frog,
There is no "bluffing" whatsoever; did you miss JohnnyFiber's post, to which I was responding?
http://investorshub.advfn.com/boards/read_msg.asp?message_id=24631509
http://findarticles.com/p/articles/mi_pwwi/is_200604/ai_n16135852
If one knows what DNA personalized medicine is, the importance of these patents is obvious. Please see these excerpt:
"The recent patent provides legal protection for DNAPrint's status as one of a very few companies currently capable of performing objective, assumption-free haplotype analyses."
So, these very few companies hold the key patents in this area. Comprendes?
http://en.wikipedia.org/wiki/Personalized_medicine
http://en.wikipedia.org/wiki/Theranostics
DNAPrint Genomics holding key patents in this explosive area is of potentially enormous significance.
Johnnyfiber,
It appears that DNAPrint Genomics holds key patents in the field of DNA Personalized Medicine, widely projected to be an astoundingly huge emerging market. DNAPrint (and/or the proposed pharma spinoff) eventually reaching Fortune 500 is not outside the realm of possibility!
Question: Is there any check here, that prevents bashers from setting up and exploiting multiple aliases, in their postings here? It doesn't appear so.
I also see Fortune 500 potential in DNAPrint Genomics, and in the pharma spinoff they've been discussing.
We would be FAR over a penny now, if it weren't for errors in judgment (like dumping millions at cheaper and cheaper prices, into a nascent and fragile rally,) constant harmful bashing, lack of appropriate levels of patience, and exploitative behaviors. My opinion, of course.
Stockboy,
Are you one of those people who constantly screams at biotech startups, R&D companies, "Where's your profit!?" as they are ramping up? Everyone knows, or should know, that such ventures take significant time to turn a profit. It's all about the building up, and eventual profit making based on, intellectual property and other advantageous factors. DNAPrint Genomics appears to be doing that quite nicely. Quit screaming down the back of their neck. For shame.
Stockboy,
Recall that recently, DNAG had a significant rally in stock price, but that was crushed very quickly by the selling of millions of shares at cheaper and cheaper prices! Hopefully people have learned their lessons now, and will not contribute to the penny stock shuffle, next time the stock price starts to rise significantly.
Frogdreaming,
Allow me to point out: BioServe, DNA Direct, Beckman Coulter... those recent deals alone refute what you said below. Clearly, multiple corporate entities, not "no one," are interested in what DNAG has to offer.
You said, "As far as I'm concerned there is absolutely no substance to the 'option' premise. It is a red herring to cover the fact that no one is remotely interested in anything DNAG has to offer."
Orchid option or not, I understand that time scale in biotech can stretch many investors' patience, especially when slowed by financing concerns. DNAPrint appears to be moving ahead in its own time, significant movement now. Extraordinary explanations are not required (though bashers have obviously played a role in driving and keeping the stock price down. Concocting conspiracy theories and behaving as wet blankets do not help shareholders. If any basher was a shareholder, he/she would be harming his/her own investment, as well. If any basher is not a shareholder today, continuing to bash is uncalled for, and harmful to others, and to DNAPrint Genomics, in my opinion.) Bashers aside, some very positive things have developed recently with DNAPrint... I think people will stop listening to the bashers, especially as things continue to improve. But by that time, people wishing to buy in, will have to do so at a higher price. People willing to take a greater degree of risk by investing earlier, including myself, stand to have better returns.
Very interesting! I think that eventually, in addition to DNA personalized medicine and DNA-guided changes to lifestyle and nutrition, etc., genetic engineering will become the social norm, to remove a whole lot of genetic risk factors from the next generation, should the parents choose to do so, and pay for it, of course. It's almost enough to cause me to delay having children, as my wife and I both have particular known risk factors in our families (atherosclerosis on my side, and diabetes on her side, for instance,) and most likely unknown risk factors, as well. Also, I speculate that the future concept of "health" will be much bigger than it is today - not only attempting to treat diseases and/or their symptoms (as is still very common today,) and not only preventing them, and using DNA Personalized medicine for enhanced results, but also improving and enhancing the human condition in general, including, probably, lifespan. (Sirtris is one such company, involved in such technological endeavors, but the FDA doesn't allow "increased lifespan" as a drug indication, so they will have to target specific diseases, to gain FDA approval, and then it can be prescribed for off-label uses. Yet I digress.)
Frogdreaming,
If you wish to dissuade people from buying DNAG stock based on these speculations of yours, surrounding the "Orchid option," you should spell out succinctly just how this "Orchid option" negatively impacts DNAPrint Genomics, its ability to form deals and conduct business, etc. Leaving it as a vague scare is not responsible or informative. Anyway, obviously deals HAVE been forged... DNA Direct, Beckman Coulter (if they hold the option, is that supposed to stop *them* from dealing with DNAPrint?,) BioServe, etc. It doesn't sound like a freeze to me. Do I smell scaremongering?
That's excellent news, Johnny! I'm pleasantly surprised! Doesn't sound like the last breaths of the company, by any stretch of the imagination! I've never been more optimistic, about DNAG's future, than I am now!!
Yes, it is impressive.
It'll be interesting what develops next week, and further down the road! Have a great weekend, everyone!
Possible DNA Personalized Medicine application - an ancedote:
I have a second cousin who is a real wet blanket, actually diagnosed (by different practitioners) with "Schizo-Affective Disorder," "Borderline Personality Disorder," AND "Antisocial Personality Disorder." Nobody invites him to parties; nothing can ever go as he wishes, so he always turns against the party, spouting conspiracy theories, and doing everything in his power to ruin everyone's fun, even going for the "extra points" of destroying relationships and making sure people never come back. I wonder if DNA Personalized Medicine, one of the fields that DNAPrint Genomics is participating in, could possibly help people like him. Perhaps special medicines could be matched with DNA results. In the meantime, I just stay away from him, as does everyone else. He makes himself a regular thorn in the side on the internet, though, where he's not gotten rid of so easily.
This is very encouraging news. I'm glad to see it reported in more places!
> DNAPrint gets California partner
I will refrain from commenting in an attempt to remain on topic, and not reward "wet blanket" behaviors.
I agree!
> Doubled my shares. This baby is going to rock!
LOL. Just trying to spread the good news as it arrives, to counter the old basher(s?)
DNAG now rated "BUY CONFIRMED" on AmericanBulls. Link here:
http://www.americanbulls.net/StockPage.asp?CompanyTicker=DNAG&MarketTicker=OTC&Typ=S
Previous rating was "BUY IF." This is actually the first time I've seen DNAG rated as "BUY CONFIRMED" at AmericanBulls. Definitely a positive sign!
You said, "Nothing here," but yet, here you are!
On the bright side, all that loss could well turn into gain, for those who chose to buy DNAG stock at low prices, as I and others have done. Rebound profits on penny stocks can be much higher than normal industry growth rates. This Beckman Coulter deal sounds like it could be very significant.
DNAPrint Genomics - Beckman Coulter deal also reported here:
http://money.cnn.com/news/newsfeeds/articles/marketwire/0328816.htm
Combined with other revnue streams and deals, this could get very interesting...!
Sorry, not interested in teaching people how to short stocks. Anyway, DNAG is at bottom, if any stock I've ever seen has ever been at bottom. With the positive developments and news, including the latest agreement (sales & marketing deal,) DNAG looks poised for a dramatic rebound. I've always thought they could stand to have a lot more exposure... this level of sales & marketing could be just the ticket.
What interests you in this stock, anyway? Are you in? Or what?
That's a good point. No matter which level of government pays for it, DNAWitness would be invaluable in so many cases.